AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Apr 2, 2021
29875_dirs_2021-04-02_935e359b-2e87-4d0d-8100-893b8b5d3136.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-02-01
Reporting Person: MERLO LARRY J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | A | 180192 | — | Acquired | 703520.9407 | Direct |
| 2021-04-01 | Common Stock | F | 81700 | $74.30 | Disposed | 622517.9407 | Direct |
| 2021-04-01 | Common Stock | F | 8651 | — | Disposed | 632946.9407 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 406633.497 | Indirect |
| Common Stock (restricted) | 21621 | Direct |
| ESOP Common Stock | 7548 | Indirect |
| Stock Unit | 688685.9876 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (5153.23) | 5153.23 | Direct | |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (273929) | 273929 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (286787) | 286787 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (338105) | 338105 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (394091) | 394091 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (545419) | 545419 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (478711) | 478711 | Direct |
Footnotes
F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
F4: Each share credit is equivalent to one share; 1-for-1 conversion.
F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F6: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F9: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F10: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F11: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F12: The number of shares subject to the option were calculated using a 30-day average price.
F13: Options became exercisable in four equal installments, commencing 4/1/2021.